ABU DHABI, UAE — Thrombolytic treatment with recombinant human pro-urokinase was non-inferior to alteplase in achieving an excellent functional outcome in acute ischemic stroke but showed a ...

Thrombolytic drugs are the main treatment for stroke, but they have often not been recommended for people who have an aneurysm in their brains that has not ruptured. A new study (“Risk of Aneurysm ...

For patients with acute ischemic stroke due to a large-vessel occlusion (LVO), administering intra-arterial thrombolytics after successful endovascular thrombectomy does not significantly improve ...

Two randomized trials found that intra-arterial urokinase and tenecteplase did not improve functional outcomes after mechanical thrombectomy in selected stroke patients. However, these results do not ...

The province announced $2.5 million on Thursday to equip advanced care paramedics with pre-hospital thrombolytics for cardiac patients.

Antithrombotic therapy aims to prevent blood clots and the serious damage they can cause. Types include anticoagulants like heparin, antiplatelets like aspirin, and emergency thrombolytics. Thrombosis ...

A new study finds that a significant portion of older adults with mild cognitive impairment or dementia develop new cardiovascular diagnoses each year that may require treatment with anticoagulants or ...

Revascularization of ischemic tissue and rescue of a still-viable penumbra are valid therapeutic goals, but the literature in support of thrombolytics in acute ischemic stroke should not be ...

Bayer has started proof-of-concept testing of a potential new therapy for patients with deep vein thrombosis (DVT) that works in a different way to current drugs. The German group has started a phase ...

These words uttered in 1901 relate directly to studies of thrombolytics for AMI. In GISSI-1 and 2 other major thrombolysis trials, the investigators did not require an informed consent of the patients ...